Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Frank

Showing results (21-30 of 129) with videos related to

Pageof 13
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 9, 2009
CREB in the pathophysiology of cancer: implications for targeting transcription factors for cancer therapyKathleen M Sakamoto, David A Frank
JAK-STAT|September 24, 2013
Screening approaches to generating STAT inhibitors: Allowing the hits to identify the targetsSarah R Walker, David A Frank
Chemmedchem|December 15, 2015
STAT3-Interacting Proteins as Modulators of Transcription Factor Function: Implications to Targeted Cancer TherapyJennifer E Yeh, David A Frank
Trends in Cancer|December 5, 2017
Targeting Oncogenic Transcription Factors: Therapeutic Implications of Endogenous STAT InhibitorsLisa N Heppler, David A Frank
Blood|April 2, 2005
The natural product honokiol induces caspase-dependent apoptosis in B-cell chronic lymphocytic leukemia (B-CLL) cellsTraci E Battle, Jack Arbiser, David A Frank
Molecular and Cellular Endocrinology|March 28, 2013
Distinct roles of STAT3 and STAT5 in the pathogenesis and targeted therapy of breast cancerSarah R Walker, Michael Xiang, David A Frank
Molecular and Cellular Pharmacology|September 28, 2011
STAT3 Inhibition by Microtubule-Targeted Drugs: Dual Molecular Effects of Chemotherapeutic AgentsSarah R Walker, Mousumi Chaudhury, David A Frank
Cancers|April 26, 2014
STAT3 Activity and Function in Cancer: Modulation by STAT5 and miR-146bSarah R Walker, Michael Xiang, David A Frank
Cancer Research|April 6, 2006
Signal transducer and activator of transcription 1 activation in endothelial cells is a negative regulator of angiogenesisTraci E Battle, Rebecca A Lynch, David A Frank
Current Opinion in Oncology|September 20, 2013
Targeting transcription factors: promising new strategies for cancer therapyJennifer E Yeh, Patricia A Toniolo, David A Frank
Pageof 13

Showing results (21-30 of 129) with videos related to

Sort By:
Pageof 13
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 9, 2009
CREB in the pathophysiology of cancer: implications for targeting transcription factors for cancer therapyKathleen M Sakamoto, David A Frank
JAK-STAT|September 24, 2013
Screening approaches to generating STAT inhibitors: Allowing the hits to identify the targetsSarah R Walker, David A Frank
Chemmedchem|December 15, 2015
STAT3-Interacting Proteins as Modulators of Transcription Factor Function: Implications to Targeted Cancer TherapyJennifer E Yeh, David A Frank
Trends in Cancer|December 5, 2017
Targeting Oncogenic Transcription Factors: Therapeutic Implications of Endogenous STAT InhibitorsLisa N Heppler, David A Frank
Blood|April 2, 2005
The natural product honokiol induces caspase-dependent apoptosis in B-cell chronic lymphocytic leukemia (B-CLL) cellsTraci E Battle, Jack Arbiser, David A Frank
Molecular and Cellular Endocrinology|March 28, 2013
Distinct roles of STAT3 and STAT5 in the pathogenesis and targeted therapy of breast cancerSarah R Walker, Michael Xiang, David A Frank
Molecular and Cellular Pharmacology|September 28, 2011
STAT3 Inhibition by Microtubule-Targeted Drugs: Dual Molecular Effects of Chemotherapeutic AgentsSarah R Walker, Mousumi Chaudhury, David A Frank
Cancers|April 26, 2014
STAT3 Activity and Function in Cancer: Modulation by STAT5 and miR-146bSarah R Walker, Michael Xiang, David A Frank
Cancer Research|April 6, 2006
Signal transducer and activator of transcription 1 activation in endothelial cells is a negative regulator of angiogenesisTraci E Battle, Rebecca A Lynch, David A Frank
Current Opinion in Oncology|September 20, 2013
Targeting transcription factors: promising new strategies for cancer therapyJennifer E Yeh, Patricia A Toniolo, David A Frank
Pageof 13